Squarepoint’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.07M Buy
+13,600
New +$2.27M ﹤0.01% 2318
2024
Q3
Sell
-7,500
Closed -$1.51M 4564
2024
Q2
$1.51M Buy
7,500
+2,500
+50% +$451K ﹤0.01% 2254
2024
Q1
$857K Sell
5,000
-3,500
-41% -$653K ﹤0.01% 2699
2023
Q4
$1.84M Sell
8,500
-14,800
-64% -$2.54M ﹤0.01% 2054
2023
Q3
$3.72M Buy
23,300
+6,900
+42% +$1.55M 0.01% 1368
2023
Q2
$4.73M Buy
+16,400
New +$4.98M 0.01% 1113

Other funds holding PODD

Squarepoint's PODD Position: Q2 2026 in Review

Squarepoint increased its Insulet (PODD) stake by 1,156% in Q2 2026, buying an estimated $41M and bringing the position to 267,642 shares worth $40.7M. The position accounts for 0.05% of the portfolio, ranked #405.

Squarepoint first reported a position in PODD in Q2 2017 and has held it in 32 quarters since. The position peaked at $70.2M in Q3 2025. 727 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Squarepoint held 267,642 shares of Insulet worth $40.7M as of Q2 2026.
  • Squarepoint bought 246,331 Insulet shares in Q2 2026, an estimated $41M.
  • Insulet made up 0.05% of Squarepoint's portfolio in Q2 2026, its #405 holding.
  • Squarepoint first reported a position in Insulet in Q2 2017 and has held it in 32 quarters since.
  • Squarepoint's Insulet position peaked at $70.2M in Q3 2025.
  • 727 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.